The 10% Credit Percentage and the Calculation of Excess Qualified Research Expenses in the Massachusetts Corporate Excise Framework

The Credit Percentage of 10% of Excess Qualified Research Expenses represents the statutory rate applied to the incremental spending a corporation directs toward innovative research activities conducted within the Commonwealth that exceed a historically derived base amount.1 Under Massachusetts law, this mechanism serves as a primary fiscal tool to incentivize sustained growth in technological development by rewarding companies that increase their research footprint relative to their prior investment levels.3

The Massachusetts Research and Development (R&D) Tax Credit is a cornerstone of the state’s economic policy, designed to foster a competitive environment for innovation-heavy sectors such as biotechnology, defense, software engineering, and advanced manufacturing.5 Codified under Massachusetts General Laws (M.G.L.) Chapter 63, Section 38M, the credit provides a direct offset against the corporate excise tax for expenses incurred during the process of discovery and experimentation.1 The 10% rate is not a flat credit on all research spending; rather, it is an incremental incentive, meaning it only applies to the “excess” portion of spending—the amount that surpasses a specific baseline or “base amount” intended to reflect the taxpayer’s normal level of research activity.1 This structure prevents the state from merely subsidizing existing operations and instead focuses taxpayer funds on stimulating new, additional research endeavors that drive job creation and long-term economic stability.5

Legislative Foundations and Regulatory Context of Section 38M

The Massachusetts research credit was enacted to align the Commonwealth’s tax code with the federal incentives provided under Internal Revenue Code (IRC) Section 41.4 While the federal credit has undergone numerous legislative shifts, the Massachusetts credit maintains a unique relationship with the federal code, often “freezing” its definitions to specific versions of the IRC while simultaneously evolving through state-specific administrative guidance.3

The Evolution of the 10% Statutory Rate

For decades, the standard credit rate in Massachusetts was established at 10% of the excess of qualified research expenses (QREs) over the base amount, mirroring the earlier versions of the federal regular research credit.1 However, as the federal government introduced the Alternative Simplified Credit (ASC), Massachusetts sought to offer a similar path for its taxpayers to simplify compliance and accommodate corporations with volatile revenue or missing historical records.2 The introduction of the Massachusetts Alternative Simplified Method (ASM) through the Economic Development Act of 2014 marked a significant shift in the state’s tax landscape.9

The ASM rate was initially introduced at a lower percentage to mitigate the immediate fiscal impact on the state’s budget while encouraging adoption.11 The rates were phased in over several years, achieving full parity with the traditional 10% rate only recently.

As shown in the table above, taxpayers filing for the 2021 tax year and beyond now enjoy a uniform 10% rate across both the Traditional and ASM calculation methods, provided they meet the requisite historical spending criteria.1 This parity has simplified tax planning for many corporations, as the decision between the two methods now rests entirely on the calculation of the “base amount” and the resulting “excess” rather than a disparity in the multiplier.2

Jurisdictional Nuance: The Massachusetts Nexus

Unlike the federal research credit, which allows for expenses incurred across the United States, the Section 38M credit is strictly limited to research activities conducted within the geographic boundaries of Massachusetts.2 This “nexus” requirement is central to the state’s revenue office guidance and is a frequent point of contention in audits.5 Every dollar of wages, supplies, and contract research must be scrutinized to ensure the physical performance of the activity occurred at a Massachusetts facility or by a Massachusetts-based employee.3

Defining Qualified Research Expenses (QREs)

The “excess QREs” to which the 10% rate is applied are composed of three primary categories of expenditure: wages, supplies, and contract research.8 Massachusetts generally adopts the federal definition of these expenses under IRC Section 41(b), but the application of the law is filtered through state-specific regulations and technical releases.1

Internal Research Expenses: Wages and Supplies

For most high-tech and life science firms, wages represent the lion’s share of the R&D credit claim.5 These wages must be paid for “qualified services,” which include the direct conduct of research, the direct supervision of research, or the direct support of research activities.11 In the context of Massachusetts, the services must be performed in-state.3

Wages are often prorated for employees who spend only a portion of their time on research activities. Massachusetts revenue guidance requires detailed documentation to support these allocations, and the “substantially all” rule (where 80% or more of an employee’s time spent on research allows for 100% of their wages to be included) is a critical component of the 10% calculation.15

External Research: The 65% Contract Research Rule

When a corporation outsources its research to a third party, it can include 65% of the amount paid as a QRE.9 This haircut accounts for the contractor’s overhead and profit, which do not qualify as direct research costs. To apply the 10% Massachusetts rate to these expenses, the taxpayer must demonstrate that the contractor performed the work at a location within the Commonwealth.9 Payments to universities or non-profit research organizations may qualify for a higher 15% rate if they meet the “basic research” definition, which involves discovery without a specific commercial objective.1

The Traditional Method: Calculating the “Base Amount”

The Traditional Method, outlined in M.G.L. c. 63, § 38M(a), determines the “excess” by comparing current year spending to a base amount that is linked to the corporation’s gross receipts.1 This method is often the preferred choice for companies with stagnant or declining sales but increasing research investments.

The Fixed-Base Ratio and Historical Receipts

The base amount is calculated as the product of the “fixed-base ratio” and the taxpayer’s average annual gross receipts for the four taxable years preceding the credit year.1 The fixed-base ratio itself is determined by taking the total QREs for the third and fourth taxable years preceding the credit year and dividing them by the gross receipts for those same two years.1

$$Fixed\text{-}Base\ Ratio = \frac{QRE_{n-3} + QRE_{n-4}}{Gross\ Receipts_{n-3} + Gross\ Receipts_{n-4}}$$

The statute mandates that this ratio cannot exceed 16%.1 This cap protects the state from excessively high credits for companies that were research-intensive relative to their revenue in the past. If a corporation’s gross receipts were zero during those years, they are effectively precluded from using the Traditional Method and must instead use the ASM.3

The 50% Minimum Base Amount Floor

A critical limitation in the Traditional Method is the “minimum base amount.” Under no circumstances can the base amount be less than 50% of the current year’s QREs.1 This floor ensures that even for a company with no prior research history or very low historical receipts, the 10% credit is effectively capped at 5% of its total current year research spending ($10\% \times (100\% – 50\%) = 5\%$).2

The Alternative Simplified Method (ASM): Simplification and Parity

The Alternative Simplified Method (ASM) under M.G.L. c. 63, § 38M(b) provides an alternative to the gross-receipts-based Traditional Method.2 It is particularly beneficial for companies that have grown significantly or those that lack historical gross receipts data.2

ASM Calculation Steps

The ASM “excess” is calculated by comparing current QREs to a base amount equal to 50% of the average QREs over the preceding three taxable years.1

1. Calculate the 3-Year Average: Sum the QREs for the three years immediately prior to the current tax year and divide by three.2
2. Determine the Base: Multiply that average by 50%.2
3. Subtract from Current QREs: The resulting “excess” is the base for the credit.2
4. Apply the 10% Rate: Multiply the excess by 0.10.1

$$Credit_{ASM} = 0.10 \times (QRE_{current} – (0.50 \times \frac{QRE_{n-1} + QRE_{n-2} + QRE_{n-3}}{3}))$$

The 5% Rate for New Researchers

For corporations that did not have qualified research expenses in any one of the three years preceding the credit year, the incremental calculation is not possible. In these instances, the state allows a flat credit equal to 5% of the current year’s Massachusetts QREs.1 This provides a lower but immediate entry point for startups and established firms entering the Massachusetts research space for the first time.9

Local State Revenue Office Guidance and Administrative Application

The Massachusetts Department of Revenue (DOR) administers the research credit through a combination of statutes, regulations, and Technical Information Releases (TIRs). These documents provide the definitive interpretation of how the 10% credit applies in practice.3

Key Technical Information Releases (TIRs)

TIRs are essential for understanding how the state responds to legislative changes or court decisions.2

• TIR 14-13 and TIR 14-16: These releases provided the initial framework for the ASM phase-in and addressed technical corrections to the 2014 Economic Development Act.3 They clarify that the 10% rate for the ASM is only available for tax years beginning on or after January 1, 2021.8
• TIR 25-3: Issued in 2025 following the State Street decision, this release is perhaps the most significant recent development in Massachusetts research tax law.2 It confirms that financial institutions (banks, investment firms, etc.) are eligible for the Section 38M credit, overturning decades of DOR policy that restricted the credit to “business corporations” taxed under Section 39.21 Furthermore, TIR 25-3 allows these entities to claim the credit retroactively via amended returns and, crucially, permits the election of the ASM on an amended return—a departure from the standard rule that ASM elections must be made on original filings.21

Regulatory Compliance: 830 CMR 63.38M

The primary regulations (830 CMR 63.38M.1 and the proposed 63.38M.2) provide granular details on calculation methods, aggregated groups, and the definition of research conducted in the Commonwealth.11 The regulations stipulate that if a taxpayer has inadequate records to compute the fixed-base ratio under the Traditional Method, they may be assigned a default ratio of 16%—the statutory maximum.3 This highlights the necessity of robust record-keeping for any company seeking to maximize its 10% credit.3

Limitations and the Effective Value of the Credit

While the statutory rate is 10%, the “effective rate”—the actual amount of tax reduction a company realizes in a given year—is often lower due to several statutory limitations.1

The $25,000 Threshold and the 75% Cap

Massachusetts law imposes a ceiling on credit usage to ensure corporations contribute a baseline level of revenue to the state.1 A corporation may use the R&D credit to offset 100% of its first $25,000 in corporate excise liability, but it can only offset 75% of any liability exceeding that $25,000 mark.1

• Example Case: A corporation with $125,000 in excise liability.

• The first $25,000 can be fully offset (Limit 1: $25,000).
• The remaining $100,000 can be offset at 75% (Limit 2: $75,000).
• Total credit usable in the current year: $100,000.
• The remaining $25,000 of the liability must be paid in cash.1

The Minimum Excise and Carryforward Rules

The credit cannot reduce the corporate excise below the minimum tax of $456.2 However, any credit that is disallowed due to these caps is not lost.1

The unlimited carryforward for credits disallowed by the 75% rule is a uniquely generous feature of the Massachusetts code, providing long-term strategic value to companies that consistently invest in research despite limited current-year tax liabilities.2

Comprehensive Example: 10% Credit Application

To demonstrate the “10% of excess QREs” in a real-world scenario, consider “MedTech-MA Corp,” a medical device manufacturer with a consistent research presence in the state.

Scenario Background for MedTech-MA Corp

• Current Year (2024) QREs: $5,000,000.
• Historical QREs (2021-2023): $4,000,000, $3,500,000, and $3,000,000.
• Average 3-Year QREs: $3,500,000.
• Prior 4-Year Avg Gross Receipts: $50,000,000.
• Fixed-Base Ratio: 4.0% (0.0400).

Calculation Under Method 1: Traditional Method

1. Determine Calculated Base: $50,000,000 \times 0.04 = \$2,000,000$.1
2. Determine Minimum Base (50% Floor): $5,000,000 \times 0.5 = \$2,500,000$.1
3. Establish Effective Base: The greater of $2,000,000 and $2,500,000 is $2,500,000.3
4. Identify Excess QREs: $\$5,000,000 – \$2,500,000 = \$2,500,000$.3
5. Calculate Credit (10%): $\$2,500,000 \times 0.10 = \mathbf{\$250,000}$.1

Calculation Under Method 2: Alternative Simplified Method (ASM)

1. Determine Base: $50\% \times \$3,500,000 = \$1,750,000$.2
2. Identify Excess QREs: $\$5,000,000 – \$1,750,000 = \$3,250,000$.2
3. Calculate Credit (10%): $\$3,250,000 \times 0.10 = \mathbf{\$325,000}$.1

Narrative Analysis of the Choice

In this scenario, MedTech-MA Corp would elect the ASM (Option 2) because it yields a credit that is $75,000 higher than the Traditional Method.2 The Traditional Method was hampered by the 50% minimum base floor, whereas the ASM’s base was derived purely from recent research spending, which was lower on average than the current year’s surge.1 This example highlights why the ASM has become the default choice for most innovative companies in Massachusetts since the rate achieved 10% parity in 2021.2

Impact on Strategic Sectors: Life Sciences and Climatetech

While the 10% rate is the baseline, the Commonwealth provides enhanced pathways for sectors deemed critical to the state’s economic future.1

Life Sciences Refundability

Certified life sciences companies can access a refundable version of the research credit.1 If authorized by the Massachusetts Life Sciences Center (MLSC), these companies can opt to receive a refund equal to 90% of their unused credit balance.1 This is a massive “cash-for-research” mechanism that supports pre-revenue biotech firms during the lengthy drug-approval process.2

The 2024 Climatetech Expansion

New legislation in 2024 created the Climatetech Tax Incentive Program, administered by the Massachusetts Clean Energy Center (CEC).27 This program offers a climatetech qualified research expenses tax credit that mirrors the Section 38M credit.27 While it is generally non-refundable, it operates under the same 10% of excess QREs logic and shares a $30 million annual cap with other clean energy incentives.27

Fiscal Statistics and the Economic Weight of the Credit

The fiscal significance of the R&D credit is evident in the state’s tax expenditure reports and revenue summaries.4 For the 2024 fiscal year, total net state tax revenues excluding the income surtax reached approximately $39.46 billion.29 The R&D tax credit remains one of the largest corporate tax expenditures for the Commonwealth, consistently utilized by thousands of corporations to reduce their excise burden.4

The DOR’s Tax Credit Transparency Reports provide insight into the scale of these claims.31 In many years, the total amount of research credits claimed exceeds hundreds of millions of dollars, reflecting the state’s deep concentration of R&D-intensive industries.4 The 10% rate is the engine behind this investment, providing a predictable and competitive multiplier for corporate tax departments to model their future Massachusetts expansions.2

Practical Considerations for Taxpayers and Practitioners

Successfully claiming the 10% credit requires meticulous attention to both federal definitions and local filing procedures.3

Filing Schedule RC and Schedule CMS

The claim process begins with the completion of Schedule RC (Research Credit).3 This form requires a line-by-line breakdown of wages, supplies, and contract costs.3 Once the credit is calculated, the taxpayer must report the amount being “used” (subject to the 75% cap) and the amount being “carried forward” on Schedule CMS (Credit Manager Summary).3

Audit Defense and the “Process of Experimentation”

DOR audits of research credits have become increasingly sophisticated.5 Auditors now look beyond simple payroll lists and demand proof of a “process of experimentation”.5 As noted in recent case law like Phoenix Design Group, Inc. v. Commissioner, the failure to identify specific technological uncertainties at the outset of a project can be fatal to a claim.15 Taxpayers should maintain:

• Project narratives that link activities to the four-part test.5
• Time-tracking data or contemporaneous engineering notes.5
• A clear nexus showing work was performed in Massachusetts.5

The Impact of Federal Amortization (Section 174)

A major headwind for R&D-intensive firms is the federal requirement to capitalize and amortize R&D costs over five years, rather than deducting them in the year incurred.6 While this is a federal income tax issue, it increases the federal tax liability for many firms, making the state-level 10% research credit even more valuable as a tool for liquidity and cash flow management.6

Conclusion: The Strategic Future of the Massachusetts Research Credit

The 10% Credit Percentage of Excess QREs is more than a simple tax rate; it is a vital signal of the Commonwealth’s commitment to its innovation economy.5 By providing a standard 10% incremental incentive across both the Traditional and Alternative Simplified methods, Massachusetts offers a flexible yet powerful mechanism for corporations to offset the high costs of discovery.2

As the regulatory landscape evolves—most notably with the inclusion of financial institutions through TIR 25-3 and the introduction of climatetech incentives—the 10% rate remains the anchor of the state’s corporate tax incentive portfolio.2 For corporations doing business in the Commonwealth, mastering the nuances of “excess” spending, the $25,000 limitation, and the rigorous documentation requirements is essential to capturing the full value of this incentive.2 In an era of global competition for scientific talent and technological leadership, the Massachusetts research credit continues to ensure that the “Spirit of America” remains inextricably linked to the spirit of innovation.5

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/